A carregar...
Understanding and learning from the success of prophylactic human papillomavirus vaccines
An estimated 5% of human cancers are caused by human papillomavirus (HPV) infections, and most of these cancers are of the cervix. Two prophylactic HPV vaccines that target the two most oncogenic virus types, HPV16 and HPV18, are now commercially available. In controlled clinical trials, the vaccine...
Na minha lista:
| Publicado no: | Nat Rev Microbiol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6309166/ https://ncbi.nlm.nih.gov/pubmed/22961341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrmicro2872 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|